2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile

C97H89F3N34O4 — CID 159911093

IUPAC2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile
SMILESCc1nnnn1-c1ccc(Nc2nccc(-c3ccc(N4CCC(O)CC4)c(C#N)c3)n2)cc1.Cn1nnc(-c2ccc(Nc3nccc(-c4ccc(N5CCC(O)CC5)c(C#N)c4)n3)cc2)n1.N#Cc1cc(-c2ccnc(Nc3ccc(-n4cnc(C(F)(F)F)n4)cc3)n2)ccc1N1CCC(O)CC1.N#Cc1cc(-c2ccnc(Nc3ccc(C4=NCN=N4)cc3)n2)ccc1N1CCC(O)CC1
InChIInChI=1S/C25H21F3N8O.2C24H23N9O.C24H22N8O/c26-25(27,28)23-31-15-36(34-23)19-4-2-18(3-5-19)32-24-30-10-7-21(33-24)16-1-6-22(17(13-16)14-29)35-11-8-20(37)9-12-35;1-16-29-30-31-33(16)20-5-3-19(4-6-20)27-24-26-11-8-22(28-24)17-2-7-23(18(14-17)15-25)32-12-9-21(34)10-13-32;1-32-30-23(29-31-32)16-2-5-19(6-3-16)27-24-26-11-8-21(28-24)17-4-7-22(18(14-17)15-25)33-12-9-20(34)10-13-33;25-14-18-13-17(3-6-22(18)32-11-8-20(33)9-12-32)21-7-10-26-24(30-21)29-19-4-1-16(2-5-19)23-27-15-28-31-23/h1-7,10,13,15,20,37H,8-9,11-12H2,(H,30,32,33);2-8,11,14,21,34H,9-10,12-13H2,1H3,(H,26,27,28);2-8,11,14,20,34H,9-10,12-13H2,1H3,(H,26,27,28);1-7,10,13,20,33H,8-9,11-12,15H2,(H,26,29,30)
InChIKeyNXEQIAKJVHDOSX-UHFFFAOYSA-N
MW1852.01 g/mol
LogP14.12
Rot. Bonds20

About 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile

2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile (PubChem CID 159911093) has the molecular formula C97H89F3N34O4 and a molecular weight of 1852.01 g/mol. Its IUPAC name is 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile.

Molecular Properties

Compound Name2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile
PubChem CID159911093
Molecular FormulaC97H89F3N34O4
Molecular Weight1852.01 g/mol
Exact Mass1850.78
IUPAC Name2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile
SMILESCc1nnnn1-c1ccc(Nc2nccc(-c3ccc(N4CCC(O)CC4)c(C#N)c3)n2)cc1.Cn1nnc(-c2ccc(Nc3nccc(-c4ccc(N5CCC(O)CC5)c(C#N)c4)n3)cc2)n1.N#Cc1cc(-c2ccnc(Nc3ccc(-n4cnc(C(F)(F)F)n4)cc3)n2)ccc1N1CCC(O)CC1.N#Cc1cc(-c2ccnc(Nc3ccc(C4=NCN=N4)cc3)n2)ccc1N1CCC(O)CC1
InChIInChI=1S/C25H21F3N8O.2C24H23N9O.C24H22N8O/c26-25(27,28)23-31-15-36(34-23)19-4-2-18(3-5-19)32-24-30-10-7-21(33-24)16-1-6-22(17(13-16)14-29)35-11-8-20(37)9-12-35;1-16-29-30-31-33(16)20-5-3-19(4-6-20)27-24-26-11-8-22(28-24)17-2-7-23(18(14-17)15-25)32-12-9-21(34)10-13-32;1-32-30-23(29-31-32)16-2-5-19(6-3-16)27-24-26-11-8-21(28-24)17-4-7-22(18(14-17)15-25)33-12-9-20(34)10-13-33;25-14-18-13-17(3-6-22(18)32-11-8-20(33)9-12-32)21-7-10-26-24(30-21)29-19-4-1-16(2-5-19)23-27-15-28-31-23/h1-7,10,13,15,20,37H,8-9,11-12H2,(H,30,32,33);2-8,11,14,21,34H,9-10,12-13H2,1H3,(H,26,27,28);2-8,11,14,20,34H,9-10,12-13H2,1H3,(H,26,27,28);1-7,10,13,20,33H,8-9,11-12,15H2,(H,26,29,30)
InChIKeyNXEQIAKJVHDOSX-UHFFFAOYSA-N
XLogP14.12
TPSA495.27 Ų
H-Bond Donors8
H-Bond Acceptors38
Rotatable Bonds20
Heavy Atoms138
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001852.01
LogP ≤ 514.12
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1038

Analyze 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile?
The IUPAC name of 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile (CID 159911093) is 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile.
What is the SMILES notation for 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile?
The canonical SMILES for 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile is Cc1nnnn1-c1ccc(Nc2nccc(-c3ccc(N4CCC(O)CC4)c(C#N)c3)n2)cc1.Cn1nnc(-c2ccc(Nc3nccc(-c4ccc(N5CCC(O)CC5)c(C#N)c4)n3)cc2)n1.N#Cc1cc(-c2ccnc(Nc3ccc(-n4cnc(C(F)(F)F)n4)cc3)n2)ccc1N1CCC(O)CC1.N#Cc1cc(-c2ccnc(Nc3ccc(C4=NCN=N4)cc3)n2)ccc1N1CCC(O)CC1.
What is the InChIKey of 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile?
The InChIKey is NXEQIAKJVHDOSX-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H21F3N8O.2C24H23N9O.C24H22N8O/c26-25(27,28)23-31-15-36(34-23)19-4-2-18(3-5-19)32-24-30-10-7-21(33-24)16-1-6-22(17(13-16)14-29)35-11-8-20(37)9-12-35;1-16-29-30-31-33(16)20-5-3-19(4-6-20)27-24-26-11-8-22(28-24)17-2-7-23(18(14-17)15-25)32-12-9-21(34)10-13-32;1-32-30-23(29-31-32)16-2-5-19(6-3-16)27-24-26-11-8-21(28-24)17-4-7-22(18(14-17)15-25)33-12-9-20(34)10-13-33;25-14-18-13-17(3-6-22(18)32-11-8-20(33)9-12-32)21-7-10-26-24(30-21)29-19-4-1-16(2-5-19)23-27-15-28-31-23/h1-7,10,13,15,20,37H,8-9,11-12H2,(H,30,32,33);2-8,11,14,21,34H,9-10,12-13H2,1H3,(H,26,27,28);2-8,11,14,20,34H,9-10,12-13H2,1H3,(H,26,27,28);1-7,10,13,20,33H,8-9,11-12,15H2,(H,26,29,30).
What are the key properties of 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile?
2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile has a molecular weight of 1852.01 g/mol, XLogP of 14.12, 20 rotatable bonds, 8 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(2-methyltetrazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(5-methyltetrazol-1-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-(3H-1,2,4-triazol-5-yl)anilino]pyrimidin-4-yl]benzonitrile;2-(4-hydroxypiperidin-1-yl)-5-[2-[4-[3-(trifluoromethyl)-1,2,4-triazol-1-yl]anilino]pyrimidin-4-yl]benzonitrile is sourced from PubChem (CID 159911093), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).